Strong in vivo antitumor responses induced by an antigen immobilized in nanogels via reducible bonds
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Strong in vivo antitumor responses induced by an antigen immobilized in nanogels via reducible bonds
Authors
Keywords
-
Journal
Nanoscale
Volume 8, Issue 47, Pages 19592-19604
Publisher
Royal Society of Chemistry (RSC)
Online
2016-09-30
DOI
10.1039/c6nr05583d
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Spontaneous Protein Adsorption on Graphene Oxide Nanosheets Allowing Efficient Intracellular Vaccine Protein Delivery
- (2016) Hui Li et al. ACS Applied Materials & Interfaces
- Orchestrating immune responses: How size, shape and rigidity affect the immunogenicity of particulate vaccines
- (2016) Naomi Benne et al. JOURNAL OF CONTROLLED RELEASE
- Development and Evaluation of Biodegradable Particles Coloaded With Antigen and the Toll-Like Receptor Agonist, Pentaerythritol Lipid A, as a Cancer Vaccine
- (2016) Kawther K. Ahmed et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Human immune cell targeting of protein nanoparticles – caveospheres
- (2016) Joshua J. Glass et al. Nanoscale
- Functionalized graphene oxide serves as a novel vaccine nano-adjuvant for robust stimulation of cellular immunity
- (2016) Ligeng Xu et al. Nanoscale
- Enzymatic induction of supramolecular order and bioactivity
- (2016) Chengbiao Yang et al. Nanoscale
- DNA–inorganic hybrid nanovaccine for cancer immunotherapy
- (2016) Guizhi Zhu et al. Nanoscale
- Adjuvant-Loaded Subcellular Vesicles Derived From Disrupted Cancer Cells for Cancer Vaccination
- (2016) Alexander S. Cheung et al. Small
- Reduction-Sensitive Dextran Nanogels Aimed for Intracellular Delivery of Antigens
- (2015) Dandan Li et al. ADVANCED FUNCTIONAL MATERIALS
- CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses
- (2015) Rodney A. Rosalia et al. BIOMATERIALS
- Immunoengineering: How Nanotechnology Can Enhance Cancer Immunotherapy
- (2015) Michael S. Goldberg CELL
- Synthetic Nanoparticles for Vaccines and Immunotherapy
- (2015) Darrell J. Irvine et al. CHEMICAL REVIEWS
- Nanoparticulate STING agonists are potent lymph node–targeted vaccine adjuvants
- (2015) Melissa C. Hanson et al. JOURNAL OF CLINICAL INVESTIGATION
- Photosensitisation facilitates cross-priming of adjuvant-free protein vaccines and stimulation of tumour-suppressing CD8 T cells
- (2015) Monika Håkerud et al. JOURNAL OF CONTROLLED RELEASE
- Polymeric nanoparticles for co-delivery of synthetic long peptide antigen and poly IC as therapeutic cancer vaccine formulation
- (2015) Sima Rahimian et al. JOURNAL OF CONTROLLED RELEASE
- Diaminosulfide based polymer microparticles as cancer vaccine delivery systems
- (2015) Sean M. Geary et al. JOURNAL OF CONTROLLED RELEASE
- Stimulation of immune systems by conjugated polymers and their potential as an alternative vaccine adjuvant
- (2015) Hua Gong et al. Nanoscale
- Gold nanocluster-based vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides
- (2015) Yu Tao et al. Nanoscale
- Exploration of graphene oxide as an intelligent platform for cancer vaccines
- (2015) Hua Yue et al. Nanoscale
- Poly(I:C) as cancer vaccine adjuvant: Knocking on the door of medical breakthroughs
- (2015) Rachid Ammi et al. PHARMACOLOGY & THERAPEUTICS
- Synthetic TRP2 long-peptide and α-galactosylceramide formulated into cationic liposomes elicit CD8 + T-cell responses and prevent tumour progression
- (2015) Silke Neumann et al. VACCINE
- Engineering New Approaches to Cancer Vaccines
- (2015) N. K. Mehta et al. Cancer Immunology Research
- Nanoporous polyelectrolyte vaccine microcarriers. A formulation platform for enhancing humoral and cellular immune responses
- (2014) Stefaan De Koker et al. JOURNAL OF CONTROLLED RELEASE
- Effect of nanovaccine chemistry on humoral immune response kinetics and maturation
- (2014) Shannon L. Haughney et al. Nanoscale
- In vivo delivery of bovine viral diahorrea virus, E2 protein using hollow mesoporous silica nanoparticles
- (2014) D. Mahony et al. Nanoscale
- Messenger RNA (mRNA) nanoparticle tumour vaccination
- (2014) Kyle K. L. Phua et al. Nanoscale
- Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity
- (2014) Kyle K. L. Phua et al. Scientific Reports
- Biomimetic Protein Nanoparticles Facilitate Enhanced Dendritic Cell Activation and Cross-Presentation
- (2013) Nicholas M. Molino et al. ACS Nano
- Size effect of amphiphilic poly(γ-glutamic acid) nanoparticles on cellular uptake and maturation of dendritic cells in vivo
- (2013) Fumiaki Shima et al. Acta Biomaterialia
- Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant
- (2013) Annina M. Hafner et al. ADVANCED DRUG DELIVERY REVIEWS
- CD40, CD80, and CD86 Costimulatory Molecules are Differentially Expressed on Murine Splenic Antigen-presenting Cells During the Pre-implantation Period of Pregnancy, and they Modulate Regulatory T-cell Abundance, Peripheral Cytokine Response, and Pregnanc
- (2013) Anna Slawek et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Size-Dependent Uptake of Particles by Pulmonary Antigen-Presenting Cell Populations and Trafficking to Regional Lymph Nodes
- (2013) Fabian Blank et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Dendritic-Cell-Based Therapeutic Cancer Vaccines
- (2013) Karolina Palucka et al. IMMUNITY
- Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery
- (2013) Karishma T. Mody et al. Nanoscale
- Nano–bio effects: interaction of nanomaterials with cells
- (2013) Liang-Chien Cheng et al. Nanoscale
- Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence
- (2013) Timothy Kottke et al. NATURE MEDICINE
- Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer
- (2013) Charles G. Drake et al. Nature Reviews Clinical Oncology
- Cancer Immunotherapy
- (2013) J. Couzin-Frankel SCIENCE
- Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?
- (2013) Stefan Nierkens et al. TRENDS IN IMMUNOLOGY
- Biodegradable Particles as Vaccine Delivery Systems: Size Matters
- (2012) Vijaya B. Joshi et al. AAPS Journal
- Factors affecting T cell responses induced by fully synthetic glyco-gold-nanoparticles
- (2012) Silvia Fallarini et al. Nanoscale
- Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors
- (2011) F. Aranda et al. CANCER RESEARCH
- Trypan Blue staining method for quenching the autofluorescence of RPE cells for improving protein expression analysis
- (2011) Girish K. Srivastava et al. EXPERIMENTAL EYE RESEARCH
- Whole protein and defined CD8+ and CD4+ peptides linked to penetratin targets both MHC class I and II antigen presentation pathways
- (2011) Dodie S Pouniotis et al. IMMUNOLOGY AND CELL BIOLOGY
- The role of surface charge density in cationic liposome-promoted dendritic cell maturation and vaccine-induced immune responses
- (2011) Yifan Ma et al. Nanoscale
- PEGylation of biodegradable dextran nanogels for siRNA delivery
- (2010) B. Naeye et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Conjugation of Methacrylamide Groups to a Model Protein via a Reducible Linker for Immobilization and Subsequent Triggered Release from Hydrogels
- (2010) Ellen Verheyen et al. MACROMOLECULAR BIOSCIENCE
- Size-Dependent Cellular Uptake and Expulsion of Single-Walled Carbon Nanotubes: Single Particle Tracking and a Generic Uptake Model for Nanoparticles
- (2009) Hong Jin et al. ACS Nano
- Regulatory T Cells and Immune Tolerance
- (2008) Shimon Sakaguchi et al. CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started